Division Description Changes — Committees — Community Affairs References Committee; Reference — 26th Nov 2024

Change	Division
senate vote 2024-11-26#11 Edited by mackay staff on 2025-03-09 15:41:44	Title ~~Committees — Community Affairs References Committee; Reference~~ Committees - Community Affairs References Committee; Reference - Use of puberty blockers Description ~~<p class="speaker">Sue Lines</p>~~ <p>I remind senators that on Monday 25 November 2024, after 6.30 pm, a division was called on the motion moved by Senator Hanson relating to a proposed reference to the Community Affairs References Committee. I understand it suits the convenience of the Senate for the deferred vote to be held now. The question is that the motion be agreed to.</p> The majority voted against a [motion](https://www.openaustralia.org.au/senate/?gid=2024-11-25.239.2) introduced by Queensland Senator [Pauline Hanson](https://theyvoteforyou.org.au/people/senate/queensland/pauline_hanson) (One Nation), which means it failed. ### Motion text > That the following matter be referred to the Community Affairs References Committee for inquiry and report by 12 February 2025: > *> The failure of Australia to adopt evidence-based safeguards** on the use of puberty blockers for gender dysphoric adolescents, aligning with international best practices, with particular reference to:* > *> (a) the dangers posed by puberty blockers, as evid*enced by poor-quality and inconclusive research on their safety and efficacy; > > (b) the inadequacy of current Australian safeguards compared to more precautionary approaches adopted in New Zealand, the United Kingdom and other nations; > *> (c) the over-reliance on experimental treatments instead of prioritising holistic, psychological and social interventions for young people exper*iencing gender dysphoria; > *> (d)** the lack of regulation and oversight of off-label prescriptions of puberty blockers in Australia;* > *> (e)** the absence of long-term data on the physical, mental health and fertility impacts of these treatments;* > > (f) the Government's role in ensuring proper medical, ethical and legal standards are applied to protect vulnerable adolescents; > > (g) the stifling of dissenting medical and scientific views in public and policy debates on gender-affirming treatments; and > > (h) any other related matters. ~~<p></p>~~ ~~<p></p>~~

~~Sue Lines~~
I remind senators that on Monday 25 November 2024, after 6.30 pm, a division was called on the motion moved by Senator Hanson relating to a proposed reference to the Community Affairs References Committee. I understand it suits the convenience of the Senate for the deferred vote to be held now. The question is that the motion be agreed to.
The majority voted against a [motion](https://www.openaustralia.org.au/senate/?gid=2024-11-25.239.2) introduced by Queensland Senator [Pauline Hanson](https://theyvoteforyou.org.au/people/senate/queensland/pauline_hanson) (One Nation), which means it failed.
### Motion text
> *That the following matter be referred to the Community Affairs References Committee for inquiry and report by 12 February 2025:*
>
> *The failure of Australia to adopt evidence-based safeguards on the use of puberty blockers for gender dysphoric adolescents, aligning with international best practices, with particular reference to:*
>
> *(a) the dangers posed by puberty blockers, as evidenced by poor-quality and inconclusive research on their safety and efficacy;*
>
> *(b) the inadequacy of current Australian safeguards compared to more precautionary approaches adopted in New Zealand, the United Kingdom and other nations;*
>
> *(c) the over-reliance on experimental treatments instead of prioritising holistic, psychological and social interventions for young people experiencing gender dysphoria;*
>
> *(d) the lack of regulation and oversight of off-label prescriptions of puberty blockers in Australia;*
>
> *(e) the absence of long-term data on the physical, mental health and fertility impacts of these treatments;*
>
> *(f) the Government's role in ensuring proper medical, ethical and legal standards are applied to protect vulnerable adolescents;*
>
> *(g) the stifling of dissenting medical and scientific views in public and policy debates on gender-affirming treatments; and*
>
> *(h) any other related matters.*
~~~~
~~~~